DIA
NYMX

Denver Investment Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Denver Investment Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-44,369
Closed -$59K – 574
2015
Q2 		$59K Buy
+44,369
New +$62K ﹤0.01% 555

Other funds holding NYMX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Denver Investment Advisors's NYMX Position: Q3 2015 in Review

Denver Investment Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2015, closing a stake of 44,369 shares — an estimated $59K sold.

Denver Investment Advisors first reported a position in NYMX in Q2 2015 and held it in 1 quarter. The position peaked at $59K in Q2 2015. 30 funds tracked by Wall St. Rank hold NYMX as of Q3 2015.

  • Denver Investment Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q3 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 44,369 Nymox Pharmaceutical Corp shares in Q3 2015, an estimated $59K.
  • Denver Investment Advisors first reported a position in Nymox Pharmaceutical Corp in Q2 2015 and held it in 1 quarter.
  • Denver Investment Advisors's Nymox Pharmaceutical Corp position peaked at $59K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2015.

Based on Denver Investment Advisors's 13F filing for Q3 2015, filed 6 Nov 2015.